Cognitive Care Solutions Improve Clinical Decision-Making
Existing cognitive care solutions have limitations that...
Read article
Suffer from dementia, and every year there are 10 million new cases1
1. World Health Organization
Said they would want to know early if they have Alzheimer's disease if it could allow for earlier treatment2
2. Alzheimer’s Association
Are undiagnosed due to the rudimentary nature of the assessment tools available today
Creyos cognitive assessments leverage 30+ years of scientifically-validated research, fMRI mapping, and incorporate hallmarks of trusted neuropsychological tests. Behavioral health questionnaires are digitized versions of industry standard screeners and condition-focused protocols follow DSM-5 diagnostic criteria.
Taking only minutes to complete, Creyos offers an immediate and precise snapshot of your patient’s cognitive function. Assessments fulfill Medicare’s requirements for evaluating cognitive health as part of the Annual Wellness Visit (AWV), helping physicians proactively manage patient cognitive health and enhance their overall care for better outcomes, faster.
Requiring only an internet connection and a tablet or computer, the FDA Class II registered Creyos platform can be used in-clinic or remotely. Assessments require no special training to administer and incorporate clear instructions. With EHR integration and automation tools, like email reminders, practices spend less time on paperwork and more time on patient care.
Providers receive a detailed results report immediately upon completion, comparing patient performance to individuals in the same demographic. Presented graphically, scores allow for quick identification of potential impairments and provide contextual information for better communication with patients.
Only Creyos enables providers to manage the full continuum of dementia care. From early detection of mild cognitive impairment to ongoing measurement, we’ve got you covered.
With a two-task assessment, Creyos helps providers detect cognitive impairment in under 3-minutes. Balancing sensitivity and specificity, it effectively differentiates between impairment and normal aging more accurately than conventional tests.
If cognitive impairment is detected through screening, providers can immediately conduct additional testing in Creyos. Aligned with the DSM-5 criteria for dementia diagnosis, testing in Creyos involves an additional four tasks and takes less than 20-minutes to complete.
Deliver superior dementia care without specialist intervention. Cognitive care planning within Creyos complies with Alzheimer's Association guidelines, helping providers create personalized and effective care plans that support caregivers and ensure patient safety.
Creyos enables easy re-testing and ongoing monitoring. With well-tuned algorithms that detect meaningful change in a patient’s performance, providers can measure symptom progression and treatment effectiveness over time and refer to longitudinal results for ongoing, objective, clinical decision making.
Creyos supports both fee for service and value-based care practices. It meets CMS requirements for neuropsychological testing and treatment, reimbursable by many public and private payers and enables detection of dementia in patients that would otherwise have gone undiagnosed.
Existing cognitive care solutions have limitations that...
Read article
Dementia is not inevitable, and in some cases can be...
Read article
Dementia is an umbrella term for conditions characterized...
Read article